Cancer Immunotherapy Using Multiplex Non-Viral Genome Engineered Immune Effector Cells: John S. Gates Seminar Series
About this Event
Branden Moriarity, PhD, is an associate professor at the University of Minnesota School of Medicine. In his upcoming presentation, Dr. Moriarity will highlight his work on cancer immunotherapy using multiplex non-viral genome engineered immune effector cells. This is a hybrid event; Attendees can join us at Hensel Phelps West, P18-1006, or on Zoom at https://ucdenver.zoom.us/j/97718315497.